Cerono G, Cree BAC, Hauser SL, Baranzini SE, et al. Reply to "Comparative Safety Profiles of Ocrelizumab and Rituximab in Multiple Sclerosis Treatment Using Real-World Evidence". Ann Neurol 2026 Apr 7. doi: 10.1002/ana.78222.
PMID: 41947435